Catalytic activities of human debrisoquine 4-hydroxylase cytochrome P450 (CYP2D6) expressed in yeast
- 18 August 1992
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 44 (4) , 617-620
- https://doi.org/10.1016/0006-2952(92)90394-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's diseaseThe Lancet, 1992
- Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobioticsBiochemical Journal, 1992
- The expression of human cytochrome P450IA1 in the yeast Saccharomyces cerevisiaeBiochemical Pharmacology, 1991
- [12] High-efficiency transformation of yeast by electroporationPublished by Elsevier ,1991
- Debrisoquine oxidation phenotype and susceptibility to lung cancer.British Journal of Clinical Pharmacology, 1990
- Inhibition of lignocaine metabolism by β-adrenoceptor antagonists in rat and human liver microsomesXenobiotica, 1989
- Tolbutamide hydroxylation by human liver microsomesBiochemical Pharmacology, 1988
- Mephenytoin hydroxylation polymorphism: Characterization of the enzymatic deficiency in liver microsomes of poor metabolizers phenotyped in vivoClinical Pharmacology & Therapeutics, 1985
- Inhibition of sparteine oxidation in human liver by tricyclic antidepressants and other drugsLife Sciences, 1983
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977